Phospho-GAB2 (S623) Antibody

What is GAB2 and why is its phosphorylation at S623 significant?

GAB2 (GRB2-associated-binding protein 2) is an adapter protein that functions downstream of various membrane receptors, including cytokine, antigen, hormone, cell matrix, and growth factor receptors to regulate multiple signaling pathways . GAB2 plays crucial roles in regulating osteoclast differentiation by mediating TNFRSF11A/RANK signaling, mast cell activation and degranulation through PI-3-kinase regulation, cell proliferation, and hematopoiesis .

Phosphorylation at serine 623 (S623) represents a key regulatory modification of GAB2 that affects its function in signal transduction cascades. This specific phosphorylation site has been studied in various cellular contexts, particularly in relation to immune cell function and oncogenic signaling. The phosphorylation status at S623 can significantly influence GAB2's ability to form signaling complexes and regulate downstream pathways.

How does phosphorylation at S623 differ from other GAB2 phosphorylation sites?

While GAB2 contains multiple phosphorylation sites including tyrosine sites like Y643 , the S623 site represents a serine phosphorylation with distinct regulatory functions. Serine/threonine phosphorylation often regulates different aspects of protein function compared to tyrosine phosphorylation. In GAB2, S623 phosphorylation may modulate protein conformation, interaction capabilities, localization, or stability in ways that differ from tyrosine phosphorylation events.

Researchers should note that antibodies targeting different phosphorylation sites (like the phospho-Y643 antibody mentioned in the search results) detect distinct signaling events and may indicate activation of different upstream kinases . For comprehensive GAB2 signaling analysis, researchers often benefit from examining multiple phosphorylation sites simultaneously.

What are the validated applications for Phospho-GAB2 (S623) Antibody?

Phospho-GAB2 (S623) antibodies have been rigorously validated for several research applications:

For Western blot applications, researchers typically observe a band at approximately 80-97 kDa corresponding to phosphorylated GAB2 . When designing experiments, it's advisable to include appropriate positive controls, such as extracts from cells treated with TNF (2500U/ml for 30 minutes) or IFN, which have been shown to induce GAB2 phosphorylation .

What is the recommended protocol for cell-based ELISA using Phospho-GAB2 (S623) Antibody?

Cell-based ELISA provides a quantitative approach for measuring Phospho-GAB2 (S623) levels in intact cells. The general protocol involves:

• Seed cells (5,000-30,000 per well) in a 96-well plate and culture overnight

• Treat cells with desired stimuli or inhibitors

• Fix cells with 4% formaldehyde solution

• Permeabilize with 0.5% Triton X-100

• Block with appropriate blocking buffer

• Incubate with primary antibodies (Anti-Phospho-GAB2 (S623) and total GAB2 antibodies)

• Incubate with HRP-conjugated secondary antibodies

• Add substrate and measure absorbance at 450 nm

For optimal results, researchers should include both phospho-specific and total protein detection to normalize phosphorylation levels, as well as GAPDH as an internal loading control . This method can detect phospho-GAB2 expression in as few as 5,000 HeLa cells, making it suitable for experiments with limited biological material .

How can I validate the specificity of Phospho-GAB2 (S623) Antibody?

Validating antibody specificity is crucial for reliable research outcomes. For Phospho-GAB2 (S623) antibody, several approaches are recommended:

• Peptide competition assay: Pre-incubate the antibody with the immunizing phospho-peptide. This should abolish or significantly reduce signal, as demonstrated in immunohistochemical staining of human breast carcinoma tissue .

• Phosphatase treatment: Treat cell lysates with phosphatase before Western blotting to confirm the phospho-specificity of the antibody.

• ELISA specificity testing: Compare antibody binding to phospho-peptide versus non-phospho peptide. Data shows that Anti-GAB2 (Phospho-Ser623) antibody is highly specific for the phospho-peptide compared to the non-phospho counterpart .

• Control cell lines: Include both positive and negative control cell lines. For example, 293 cells, HeLa cells, and HepG2 cells have been validated for GAB2 (phospho S623) expression .

What are common issues when working with Phospho-GAB2 (S623) Antibody and how can they be resolved?

When working with phospho-specific antibodies, researchers may encounter several challenges:

• Weak or no signal: This could result from:

  • Low expression of phosphorylated protein

  • Insufficient stimulation of cells

  • Dephosphorylation during sample preparation

  Solution: Stimulate cells with known activators like TNF (2500U/ml for 30 minutes) or IFN. Include phosphatase inhibitors in lysis buffers. For Western blots, load more protein (at least 5μg per lane) .

• High background: This may be caused by:

  • Insufficient blocking

  • Too high antibody concentration

  • Cross-reactivity

  Solution: Optimize blocking conditions, dilute antibody further (start with 1:1000 for WB, 1:100 for IHC), and ensure thorough washing between incubation steps .

• Non-specific bands: May result from:

  • Cross-reactivity with other phosphorylated proteins

  • Degradation products

  Solution: Validate with blocking peptides, include proper positive and negative controls, and optimize antibody dilution and incubation time .

What are the optimal storage conditions for maintaining Phospho-GAB2 (S623) Antibody activity?

To preserve antibody activity and specificity:

• Store antibody at -20°C or -80°C for long-term storage

• Avoid repeated freeze-thaw cycles

• For working aliquots, store at 4°C (stable for up to one month)

• Many commercial preparations contain 50% glycerol, 0.5% BSA, and 0.02% sodium azide as stabilizers

The antibody formulation typically consists of PBS (pH 7.4, without Mg²⁺ and Ca²⁺) containing 50% glycerol and 0.02% sodium azide . Under recommended storage conditions, the antibody should maintain activity until the expiration date indicated on the product documentation.

How can I use Phospho-GAB2 (S623) Antibody to study signaling pathway dynamics?

To investigate signaling dynamics involving GAB2 phosphorylation:

• Time-course experiments: Treat cells with stimuli (e.g., TNF, IFN) and collect samples at different time points (0, 5, 15, 30, 60 minutes) to monitor phosphorylation kinetics.

• Inhibitor studies: Pre-treat cells with pathway-specific inhibitors before stimulation to identify upstream kinases responsible for S623 phosphorylation.

• Co-immunoprecipitation: Use phospho-GAB2 (S623) antibody to precipitate protein complexes associated with phosphorylated GAB2, followed by mass spectrometry or Western blotting to identify binding partners.

• Dual phosphorylation analysis: Compare phosphorylation patterns at S623 with other sites (e.g., Y643) to understand integrated signaling responses .

• Cell-based ELISA quantification: Measure relative phosphorylation levels across different experimental conditions using the colorimetric cell-based ELISA format .

What experimental controls should be included when studying GAB2 phosphorylation?

Robust experimental design requires appropriate controls:

• Positive controls:

  • Cell lysates from TNF-treated Jurkat cells (2500U/ml for 30 minutes)

  • IFN-treated cell extracts (2500U/ml for 30 minutes)

• Negative controls:

  • Untreated/unstimulated cells

  • Phosphatase-treated lysates

  • Secondary antibody-only wells in cell-based ELISA

• Normalization controls:

  • Total GAB2 antibody detection

  • GAPDH as loading control for Western blots or cell-based ELISAs

  • For cell-based assays, ensure equal cell numbers across wells or normalize to total protein content

• Antibody specificity controls:

  • Blocking peptide competition assays

  • Phospho-peptide versus non-phospho peptide ELISA comparisons

How can GAB2 phosphorylation at S623 be correlated with specific cellular functions?

To establish functional relevance of S623 phosphorylation:

• Site-directed mutagenesis: Generate S623A (phospho-deficient) or S623D/E (phospho-mimetic) mutants to study the impact on GAB2 function.

• Functional assays: Correlate S623 phosphorylation with:

  • Cell proliferation assays

  • Migration and invasion assays (particularly relevant in cancer research)

  • Mast cell degranulation assays

  • Osteoclast differentiation assays

• Subcellular localization: Use immunofluorescence with phospho-specific and total GAB2 antibodies to determine if phosphorylation alters protein localization.

• Protein-protein interaction studies: Investigate how S623 phosphorylation affects GAB2 interactions with known binding partners using co-immunoprecipitation or proximity ligation assays.

• Pathway activation analysis: Examine downstream signaling events (e.g., PI3K/AKT activation) in relation to S623 phosphorylation status.

What are the detailed specifications of commercial Phospho-GAB2 (S623) Antibodies?

Commercial Phospho-GAB2 (S623) antibodies typically share these characteristics:

These antibodies recognize endogenous levels of GAB2 protein only when phosphorylated at serine 623, making them valuable tools for specific detection of this phosphorylation event .

How are Phospho-GAB2 (S623) Antibodies validated during production?

Commercial antibodies undergo rigorous validation processes:

• ELISA testing: Demonstrates binding specificity to phospho-peptide versus non-phospho peptide counterparts .

• Western blot analysis: Confirms detection of a single band of appropriate molecular weight in relevant cell lines (e.g., Jurkat, 293, HeLa, HepG2) .

• Peptide competition assays: Verifies signal reduction when antibody is pre-incubated with immunizing phospho-peptide .

• Immunohistochemistry: Validates specific staining in relevant tissues (e.g., human breast carcinoma) that can be blocked by immunizing peptide .

• Batch-to-batch consistency testing: Ensures reproducible performance across manufacturing lots.

• Cross-reactivity testing: Confirms lack of cross-reactivity with other phosphorylation sites on GAB2 or related proteins.